Taurine and atherosclerosis

Amino Acids

Volumn 46, Issue 1, 2014, Pages 73-80

  Murakami, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Artery; Atherosclerosis; Cardiovascular disease; Taurine

Indexed keywords

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; HUMANS; HYPERLIPIDEMIAS; MYOCARDIAL INFARCTION; TAURINE;

EID: 84895901157     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1432-6     Document Type: Review

References (81)

1. Abebe W, Mozaffari MS (2000) Effects of chronic taurine treatment on reactivity of the rat aorta. Amino Acids 19:615-623
2. Abebe W, Mozaffari MS (2003) Taurine depletion alters vascular reactivity in rats. Can J Physiol Pharmacol 81:903-909
3. Abebe W, Mozaffari MS (2011) Role of taurine in the vasculature: an overview of experimental and human studies. Am J Cardiovasc Dis 1:293-311
4. Alfieri RR, Cavazzoni A, Petronini PG, Bonelli MA, Caccamo AE, Borghetti AF, Wheeler KP (2002) Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol 540(Pt 2):499-508
5. Atahanov SE, Elizarova EP (1992) Modulation of receptor-dependent increase of calcium ions in human platelets by taurine. Arzneimittelforschung 42:1311-1313
6. Balkan J, Kanbaǧli O, Hatipoǧlu A, Kücük M, Cevikbaş U, Aykaç-Toker G, Uysal M (2002) Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 66:1755-1758
7. Casey RG, Gang C, Joyce M, Bouchier-Hayes DJ (2007) Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res 44:31-39
8. Chen X, Sebastian BM, Tang H, McMullen MM, Axhemi A, Jacobsen DW, Nagy LE (2009) Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 49:1554-1562
9. Chen W, Guo JX, Chang P (2012) The effect of taurine on cholesterol metabolism. Mol Nutr Food Res 56:681-690
10. Chiba Y, Ando K, Fujita T (2002) The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats. J Hypertens 20:2269-2274
11. De Luca G, Calpona PR, Caponetti A, Romano G, Di Benedetto A, Cucinotta D, Di Giorgio RM (2001) Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients. Metabolism 50:60-64
12. Egan BM, Chen G, Kelly CJ, Bouchier-Hayes DJ (2001) Taurine attenuates LPS-induced rolling and adhesion in rat microcirculation. J Surg Res 95:85-91
13. Fennessy FM, Moneley DS, Wang JH, Kelly CJ, Bouchier-Hayes DJ (2003) Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation 107:410-415
14. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R, Seghieri G (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61:1115-1119
15. Fukuda N, Yoshitama A, Sugita S, Fujita M, Murakami S (2011) Dietary taurine reduces hepatic secretion of cholesteryl ester and enhances fatty acid oxidation in rats fed a high-cholesterol diet. J Nutr Sci Vitaminol 57:144-149
16. Gokce G, Ozsarlak-Sozer G, Oran I, Oktay G, Ozkal S, Kerry Z (2011) Taurine suppresses oxidative stress-potentiated expression of lectin-like oxidized low-density lipoprotein receptor and restenosis in balloon-injured rabbit iliac artery. Clin Exp Pharmacol Physiol 38:811-818
17. Guz G, Oz E, Lortlar N, Ulusu NN, Nurlu N, Demirogullari B, Omeroglu S, Sert S, Karasu C (2007) The effect of taurine on renal ischemia/reperfusion injury. Amino Acids 32:405-411
18. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204-212
19. Hayes KC, Pronczuk A, Addesa AE, Stephan ZF (1989) Taurine modulates platelet aggregation in cats and humans. Am J Clin Nutr 49:1211-1216
20. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163
21. Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529-1539
22. Kamata K, Sugiura M, Kojima S, Kasuya Y (1996) Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. Eur J Pharmacol 303:47-53
23. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y (2002) Oxidation of Ikappa Bα at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation. J Biol Chem 277:24049-24056
24. Kempf E, Ebel A, Wendling S, Bollack C, Mandel P (1970) The distribution of free amino acids in arterial walls and their modifications during aging. Rev Eur Etud Clin Biol 15:857-861
25. Kibayashi E, Yokogoshi H, Mizue H, Miura K, Yoshita K, Nakagawa H, Naruse Y, Sokejima S, Kagamimori S (2000) Daily dietary taurine intake in Japan. Adv Exp Med Biol 483:137-142
26. Kondo Y, Toda Y, Kitajima H, Oda H, Nagate T, Kameo K, Murakami S (2001) Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice. Clin Exp Pharmacol Physiol 28:809-815
27. Learn DB, Fried VA, Thomas EL (1990) Taurine and hypotaurine content of human leukocytes. J Leukoc Biol 48:174-182
28. Liao XB, Zhou XM, Li JM, Tan ZP, Liu LM, Zhang W, Tan H, Lu Y, Yuan LQ (2007) Taurine transporter is expressed in vascular smooth muscle cells. Amino Acids 33:639-643
29. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
30. Liu Y, Niu L, Zhang W, Cui L, Zhang X, Liang Y, Zhang M (2009) Effects of taurine on contractions of the porcine coronary artery. Pharmacol Rep 61:681-689
31. Lobo MV, Alonso FJ, Martin del Rio R (2000) Immunocytochemical localization of taurine in different muscle cell types of the dog and rat. Histochem J 32:53-61
32. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29-38
33. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 267:4495-4503
34. Malle E, Wäg G, Thiery J, Sattler W, Gröne HJ (2001) Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol. Biochem Biophys Res Commun 289:894-900
35. Manolopoulos VG, Voets T, Declercq PE, Droogmans G, Nilius B (1997) Swelling-activated efflux of taurine and other organic osmolytes in endothelial cells. Am J Physiol 273(1 Pt 1):C214-C222
36. Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B (1998a) Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40:27-38
37. Marcinkiewicz J, Grabowska A, Chain BM (1998b) Modulation of antigen-specific T-cell activation in vitro by taurine chloramine. Immunology 94:325-330
38. Marsche G, Zimmermann R, Horiuchi S, Tandon NN, Sattler W, Malle E (2003) Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J Biol Chem 278:47562-47570
39. Matsushima Y, Sekine T, Kondo Y, Sakurai T, Kameo K, Tachibana M, Murakami S (2003) Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice. Clin Exp Pharmacol Physiol 30:295-299
40. Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y (1996) Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52:303-313
41. Murakami S, Kondo-Ohta Y, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83-91
42. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T (2002a) Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 163:79-87
43. Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N (2002b) Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70:2355-2366
44. Murakami S, Sakurai T, Tomoike H, Sakono M, Nasu T, Fukuda N (2010a) Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation. Amino Acids 38:271-278
45. Murakami S, Sakurai T, Toda Y, Morito A, Sakono M, Fukuda N (2010b) Prevention of neointima formation by taurine ingestion after carotid balloon injury. Vascul Pharmacol 53:177-184
46. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S (2005) Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182:1-15
47. Nishida S, Satoh H (2009) Vascular modulation of rat aorta by taurine. Adv Exp Med Biol 643:37-46
48. Ogura S, Kakino A, Sato Y, Fujita Y, Iwamoto S, Otsui K, Yoshimoto R, Sawamura T (2009) Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J 73:1993-1999
49. Park E, Schuller-Levis G, Quinn MR (1995) Taurine chloramine inhibits production of nitric oxide and TNF-alpha in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 154:4778-4784
50. Petty MA, Kintz J, DiFrancesco GF (1990) The effects of taurine on atherosclerosis development in cholesterol-fed rabbits. Eur J Pharmacol 180:119-127
51. Podrez EA, Abu-Soud HM, Hazen SL (2000) Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28:1717-1725
52. Qian X, Vinnakota S, Edwards C, Sarkar HK (2000) Molecular characterization of taurine transport in bovine aortic endothelial cells. Biochim Biophys Acta 1509:324-334
53. Rosenson RS (2003) Modulating atherosclerosis through inhibition or blockade of angiotensin. Clin Cardiol 26:305-311
54. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
55. Schaffer SW, Lombardini JB, Azuma J (2000) Interaction between the actions of taurine and angiotensin II. Amino Acids 18:305-318
56. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM (2007) Renin-angiotensin system and cardiovascular risk. Lancet 369:1208-1219
57. Schuller-Levis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neurochem Res 29:117-126
58. Silva LA, Silveira PC, Ronsani MM, Souza PS, Scheffer D, Vieira LC, Benetti M, De Souza CT, Pinho RA (2011) Taurine supplementation decreases oxidative stress in skeletal muscle after eccentric exercise. Cell Biochem Funct 29:43-49
59. Spohr C, Brøns C, Winther K, Dyerberg J, Vaag A (2005) No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus. Platelets 16:301-305
60. Takahashi K, Azuma M, Taira K, Baba A, Yamamoto I, Schaffer SW, Azuma J (1997) Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J Cardiovasc Pharmacol 30:725-730
61. Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ (2007) Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vascul Pharmacol 46:338-345
62. Terauchi A, Nakazawa A, Johkura Y, Yan L, Usuda N (1998) Immunohistochemical localization of taurine in various tissues of the mouse. Amino Acids 15:151-160
63. Ulrich-Merzenich G, Zeitler H, Vetter H, Bhonde RR (2007) Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins. Eur J Nutr 46:431-438
64. Vaughan CJ, Gotto AM Jr, Basson CT (2000) The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35:1-10
65. Wang JH, Redmond HP, Watson RW, Condron C, Bouchier-Hayes D (1996) The beneficial effect of taurine on the prevention of human endothelial cell death. Shock 6:331-338
66. Wang LJ, Yu YH, Zhang LG, Wang Y, Niu N, Li Q, Guo LM (2008) Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur J Pharmacol 597:75-80
67. Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D (2001) Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 280:G1274-G1279
68. Weiss SJ, Klein R, Slivka A, Wei M (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 70:598-607
69. Welles EG, Boudreaux MK, Tyler JW (1993) Platelet, antithrombin, and fibrinolytic activities in taurine-deficient and taurine-replete cats. Am J Vet Res 54:1235-1243
70. Wójcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y (2010) The potential protective effects of taurine on coronary heart disease. Atherosclerosis 208:19-25
71. Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D (1999) Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 277(6 Pt 1):C1229-C1238
72. Yamamoto K, Yoshitama A, Sakono M, Nasu T, Murakami S, Fukuda N (2000) Dietary taurine decreases hepatic secretion of cholesterol ester in rats fed a high-cholesterol diet. Pharmacology 60:27-33
73. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y, WHO-Cardiovascular Disease and Alimentary Comprarison (CARDIAC) Study Group (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 24:453-457
74. Yamori Y, Liu L, Mori M, Sagara M, Murakami S, Nara Y, Mizushima S (2009) Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 643:13-25
75. Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M (2010) Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. J Biomed Sci 17(Suppl 1):S6
76. Yanagita T, Han SY, Hu Y, Nagao K, Kitajima H, Murakami S (2008) Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis 7:38
77. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H (1999) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129:1705-1712
78. Yoshimura H, Nariai Y, Terashima M, Mitani T, Tanigawa Y (2005) Taurine suppresses platelet-derived growth factor (PDGF) BB-induced PDGF-β receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells. Biochim Biophys Acta 1745:350-360
79. Zhang X, Tenner TE Jr, Lombardini JB (1999) Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues. Biochem Pharmacol 57:1331-1339
80. Zulli A (2011) Taurine in cardiovascular disease. Curr Opin Clin Nutr Metab Care 14:57-60
81. Zulli A, Lau E, Wijaya BP, Jin X, Sutarga K, Schwartz GD, Learmont J, Wookey PJ, Zinellu A, Carru C, Hare DL (2009) High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension 53:1017-1022